glp-1 drugs America's Poison Centers The GLP-1 Revolution: From Diabetes
Description
significant weight reduction (~ 710%) through calorie restriction, with or without exercise, and bariatric/metabolic surgery results in high turnover bone loss
Higher doses often cost more than lower doses
Peptides 1994
Haffner, S
The first cohort comprised individuals who started and continued either a GLP-1 receptor agonist or DPP-4 inhibitor for the first time between January 1, 2007, and December 31, 2020
Diabetes Care 41, 26692701
